Literature DB >> 22869331

Breast cancer: Fewer therapy cycles is better.

Lisa Hutchinson.   

Abstract

Entities:  

Year:  2012        PMID： 22869331     DOI： 10.1038/nrclinonc.2012.139

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.

Authors:  Lawrence N Shulman; Constance T Cirrincione; Donald A Berry; Heather P Becker; Edith A Perez; Ruth O'Regan; Silvana Martino; James N Atkins; Erica Mayer; Charles J Schneider; Gretchen Kimmick; Larry Norton; Hyman Muss; Eric P Winer; Clifford Hudis
Journal:  J Clin Oncol       Date:  2012-07-23       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.